Panel · Use case · Market Access

Formulary Committee Rehearsal.

LiveStakeholder Rehearsal

Rehearse a formulary committee discussion for a specialty drug with simulated payer, pharmacist, clinician and finance voices.

MeetingA formulary committee discussion of a new specialty drug

ConstituenciesMedical director, pharmacist, clinician, finance lead

ReaderAccess and HEOR leads

Not askedA prediction of the decision

DepthStandard, four seats

Formulary Committee Rehearsal is a ready-made use case for Market Access. It ships under the Stakeholder Rehearsal template.

For market access leads. You get each simulated constituency's position, where they conflict, the objections with proposed responses and what each would need to move. The constituencies are simulated, not consulted. Claims are cited or marked as gaps.

Add it to your library to reuse from New → From template. Edit the saved copy in your library on the service form.

The decision

How will a formulary committee of a payer medical director, a pharmacist, a treating clinician and a finance lead discuss a new specialty drug?

Who is simulated

Formulary committees work from a dossier in a common format and from the policies of the pharmacy benefit manager. The seats are briefed on both.

Constituency simulated	What it is asked	What it works from
Payer medical director	Whether the clinical evidence supports coverage and under what criteria.^{1Academy of Managed Care Pharmacy. AMCP Format for Formulary Submissions, Version 4.1. December 2019.}	The AMCP Format and published coverage policies.
Pharmacist	Utilization controls, alternatives on the formulary and operational burden.	Formulary design practice.
Treating clinician	Whether the drug adds to what is available and which patients need it.	Guidelines and clinical evidence.
Finance lead	Budget impact and the effect of rebates in a concentrated market.^{2U.S. Federal Trade Commission. Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. Interim staff report, 9 July 2024.}	The FTC’s report on pharmacy benefit managers.

What the rehearsal does

The objections to expect. Payers examine modest gains on surrogate endpoints, small populations and budget impact. The report lists the likely objections in the order they would be raised, each with an evidence-backed response.^{1Academy of Managed Care Pharmacy. AMCP Format for Formulary Submissions, Version 4.1. December 2019.}

Market structure shapes the finance seat. The FTC reported that three managers processed nearly 80 percent of prescriptions in 2023. The finance seat notes what that means for the leverage of the committee.^{2U.S. Federal Trade Commission. Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. Interim staff report, 9 July 2024.}

What each would need to move. The report states, for each seat, the evidence or term that would change its stance.

Recommended length

Standard

Four constituencies are in the room. Standard depth gives each a seat and ends with what a rehearsal cannot tell you, in about four pages.

You can pick another length on the form. The other two stay available.

Assumptions the rehearsal checks

The rehearsal states the assumptions it makes about each constituency, and says what each gap limits. Examples for this meeting:

The committee uses the dossier format and not a bespoke template.
The pharmacy benefit manager’s policy for the class is public.
The finance lead has a rebate range in mind.

Standards, guidance and sources

Frame

AMCP Format for Formulary Submissions, version 4.1.^{1Academy of Managed Care Pharmacy. AMCP Format for Formulary Submissions, Version 4.1. December 2019.}
FTC, interim staff report on pharmacy benefit managers, July 2024.^{2U.S. Federal Trade Commission. Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. Interim staff report, 9 July 2024.}

The decision practice behind the memo itself is on the template page.

What gets flagged

Any rebate or price assumption not supplied by the sponsor, any policy attributed to a payer without a source, and any objection with no prepared response.

What arrives

The question put, and who was simulated
The stakeholder map
Each constituency's position
Where they conflict
Objections and responses
What each would need to move, and the order to engage
What a rehearsal cannot tell you

What it will not do

The constituencies are simulated by AI specialists and are not the real people. The rehearsal prepares you for objections you can anticipate and does not predict the live room.

It does not negotiate on behalf of the company.

It is not research with real stakeholders. The constituencies are simulated by AI specialists from stated sources, and they are not the real people.

It does not predict what the live room will say. It prepares you for the objections you can anticipate.

It does not script a response to be repeated. The responses are for you to test and to adapt.

References

[1] Academy of Managed Care Pharmacy. AMCP Format for Formulary Submissions, Version 4.1. December 2019. Scope and status as given in AMCP’s release; not read in full.
[2] U.S. Federal Trade Commission. Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. Interim staff report, 9 July 2024. Figures as given in the FTC’s press release and search excerpts; not read in full.

Links checked 9 October 2026

These are the sources the template drew on. None of their authors or issuers has reviewed it.

About the Panel service

Each panelist answers in their own voice, then the discussion is drawn together. You get the question and who was in the room, every position in full, what they agreed on, where they split, and what follows. Disagreements are written down rather than smoothed into a consensus nobody actually holds, because the split is usually the part you needed.

To edit a saved template, open New → Panel → From template, or the library rail on the service form.